Heterologous cell-cell interactions: Thromboregulation, cerebroprotection and cardioprotection by CD39 (NTPDase-1)

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 12, 2003, Pages 2497-2509

  Marcus, A J ^a,b   Broekman, M J ^a,b   Drosopoulos, J H F ^a,b   Islam, N ^a,b   Pinsky, D J ^c   Sesti, C ^a   Levi, R ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Columbia University ^*  (United States)

Author keywords

Coronary artery disease; Ecto nucleotidase; Stroke; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASE; APYRASE; CD39 ANTIGEN; LEUKOCYTE ANTIGEN;

ANIMAL; BLOOD; CELL COMMUNICATION; DRUG EFFECT; ENDOTHELIUM CELL; ENZYMOLOGY; GENETICS; HEMOSTASIS; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; THROMBOSIS;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATASES; ANIMALS; ANTIGENS, CD; APYRASE; ASPIRIN; CELL COMMUNICATION; ENDOTHELIAL CELLS; HEMOSTASIS; HUMANS; THROMBOSIS;

EID: 1542440333     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2003.00479.x     Document Type: Review

References (59)

1. Marcus AJ, Broekman MJ, Drosopoulos JHF, Islam N, Pinsky DJ, Sesti C, Levi R. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases. J Pharmacol Exp Ther 2003; 305: 9-16.
2. Marcus AJ, Broekman MJ, Drosopoulos JHF, Pinsky DJ, Islam N, Gayle RB III, Maliszewski C. Thromboregulation by endothelial cells: significance for occlusive vascular diseases. Arterioscler Thromb Vasc Biol 2001; 21: 178-82.
3. 4. J Biol Chem 1988; 263: 174-81.
4. Marcus AJ, Safier LB, Ullman HL, Islam N, Broekman MJ, Falck JR, Fischer S, von Schacky C. Platelet-neutrophil interactions. (12S)hydroxyeicosatetraen-1,20-dioic acid: a new eicosanoid synthesized by unstimulated neutrophils from (12S)-20-dihydroxyeicosatetraenoic acid. J Biol Chem 1988; 263: 2223-9.
5. Marcus AJ, Broekman MJ, Safier LB, Ullman HL, Islam N, Serhan CN, Rutherford LE, Korchak HM, Weissmann G. Formation of leukotrienes and other hydroxy acids during platelet-neutrophil interactions in vitro. Biochem Biophys Res Commun 1982; 109: 130-7.
6. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-74.
7. Ross R. Mechanisms of disease: atherosclerosis-an inflammatory disease. NEngl J Med 1999; 340: 115-26.
8. Marcus AJ, Safier LB, Hajjar KA, Ullman HL, Islam N, Broekman MJ, Eiroa AM. Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells. J Clin Invest 1991; 88: 1690-6.
9. Marcus AJ, Broekman MJ, Drosopoulos JHF, Islam N, Alyonycheva TN, Safier LB, Hajjar KA, Posnett DN, Schoenborn MA, Schooley KA, Gayle RB, Maliszewski CR. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997; 99: 1351-60.
10. Marcus AJ, Weksler BB, Jaffe EA, Broekman MJ. Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells. J Clin Invest 1980; 66: 979-86.
11. Schafer AI, Crawford DD, Gimbrone MA Jr. Unidirectional transfer of prostaglandin endoperoxides between platelets and endothelial cells. J Clin Invest 1984; 73: 1105-12.
12. Zimmermann H, Beaudoin AR, Bollen M, Goding JW, Guidotti G, Kirley TL, Robson SC, Sano K. Proposed nomenclature for two novel nucleotide hydrolyzing enzyme families expressed on the cell surface. In: Vanduffel L, Lemmens R, eds. Ecto-ATPases and Related Ectonucleotidases. Proceedings of the Second International Workshop on EctoATPases and Related Ectonucleotidases. Maastricht: Shaker Publishing, 2000: 1-8.
13. Marcus AJ, Safier LB. Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis. FASEB J 1993; 7: 516-22.
14. Serhan CN. Lipoxins and novel aspirin-triggered 15-epi-lipoxins (ATL): a jungle of cell-cell interactions or a therapeutic opportunity? Prostaglandins 1997; 53: 107-37.
15. 4. Nat Med 2002; 8: 1018-23.
16. Marcus AJ, Hajjar DP. Vascular transcellular signalling. J Lipid Res 1993; 34: 2017-32.
17. Serhan CN, Haeggström JZ, Leslie CC. Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J 1996; 10: 1147-58.
18. Karim S, Habib A, Levy-Toledano S, Maclouf J. Cyclooxygenases-1 and -2 of endothelial cells utilize exogenous or endogenous arachidonic acid for transcellular production of thromboxane. J Biol Chem 1996; 271: 12042-8.
19. Sesti C, Broekman MJ, Drosopoulos JHF, Islam N, Marcus AJ, Levi R. Ectonucleotidase in cardiac sympathetic nerve endings modulates ATPmediated feedback of norepinephrine release. J Pharmacol Exp Ther 2002; 300: 605-11.
20. Nathan C. Points of control in inflammation. Nature 2002; 420: 846-52.
21. Marcus AJ. Platelets: their role in hemostasis, thrombosis, and inflammation. In: Gallin JI, Snyderman R, eds. Inflammation: Basic Principles and Clinical Correlates. Philadelphia: Lippincott, Williams & Wilkins, 1999: 77-95.
22. Broekman MJ, Eiroa AM, Marcus AJ. Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension. Blockade of aggregation and secretion by an aspirin-insensitive mechanism. Blood 1991; 78: 1033-40.
23. Plesner L. Ecto-ATPases: identities and functions. Int Rev Cytol 1995; 158: 141-214.
24. Handa M, Guidotti G. Purification and cloning of a soluble ATPdiphosphohydrolase (apyrase) from potato tubers (Solanum tuberosum). Biochem Biophys Res Commun 1996; 218: 916-23.
25. Kaczmarek E, Koziak K, Sévigny J, Siegel JB, Anrather J, Beaudoin AR, Bach FH, Robson SC. Identification and characterization of CD39 vascular ATP diphosphohydrolase. J Biol Chem 1996; 271: 33116-22.
26. Maliszewski CR, Delespesse GJ, Schoenborn MA, Armitage RJ, Fanslow WC, Nakajima T, Baker E, Sutherland GR, Poindexter K, Birks C, et al. The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J Immunol 1994; 153: 3574-83.
27. Kansas GS, Wood GS, Tedder TF. Expression, distribution, and biochemistry of human CD39. Role in activation-associated homotypic adhesion of lymphocytes. J Immunol 1991; 146: 2235-44.
28. Kirley TL, Yang F, Ivanenkov VV. Site-directed mutagenesis of human nucleoside triphosphate diphosphohydrolase 3: the importance of conserved glycine residues and the identification of additional conserved protein motifs in eNTPDases. Arch Biochem Biophys 2001; 395: 94-102.
29. Gendron FP, Benrezzak O, Krugh BW, Kong Q, Weisman GA, Beaudoin AR. Purine signaling and potential new therapeutic approach: possible outcomes of NTPDase inhibition. Curr Drug Targets 2002; 3: 229-45.
30. Schulte am Esch J, Sévigny J, Kaczmarek E, Siegel JB, Imai M, Koziak K, Beaudoin AR, Robson SC. Structural elements and limited proteolysis of CD39 influence ATP diphosphohydrolase activity. Biochemistry 1999; 38: 2248-58.
31. Smith TM, Lewis Carl SA, Kirley TL. Mutagenesis of two conserved tryptophan residues of the E-type ATPases: inactivation and conversion of an ecto-apyrase to an ecto-NTPase. Biochemistry 1999; 38: 5849-57.
32. Pinsky DJ, Broekman MJ, Peschon JJ, Stocking KL, Fujita T, Ramasamy R, Connolly ES Jr, Huang J, Kiss S, Zhang Y, Choudhri TF, McTaggart RA, Liao H, Drosopoulos JH, Price VL, Marcus AJ, Maliszewski CR. Elucidation of the thromboregulatory role of CD39/ ectoapyrase in the ischemic brain. J Clin Invest 2002; 109: 1031-40.
33. Gayle RB III, Maliszewski CR, Gimpel SD, Schoenborn MA, Caspary RG, Richards C, Brasel K, Price V, Drosopoulos JH, Islam N, Alyonycheva TN, Broekman MJ, Marcus AJ. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. J Clin Invest 1998; 101: 1851-9.
34. Marcus AJ, Broekman MJ, Pinsky DJ. COX inhibitors and thromboregulation. NEngl J Med 2002; 347: 1025-6.
35. Drosopoulos JHF, Broekman MJ, Islam N, Maliszewski CR, Gayle RB III, Marcus AJ. Site-directed mutagenesis of human endothelial cell ecto-ADPase/soluble CD39. Requirement of glutamate174 and serine218 for enzyme activity and inhibition of platelet recruitment. Biochemistry 2000; 39: 6936-43.
36. + utilization by soluble human CD39/ecto-nucleotidase. Arch Biochem Biophys 2002; 406: 85-95.
37. De Girolami U, Anthony DC, Frosch MP. The central nervous system. In: Cotran RS, Kumar V, Collins T, eds. Pathologic Basis of Disease. New York: W.B. Saunders, 1999: 1306-14.
38. Choudhri TF, Hoh BL, Zerwes HG, Prestigiacomo CJ, Kim SC, Connolly ES, Kottirsch G, Pinsky DJ. Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb/IIIa receptor-mediated platelet aggregation. J Clin Invest 1998; 102: 1301-10.
39. Choudhri TF, Hoh BL, Prestigiacomo CJ, Huang J, Kim LJ, Schmidt AM, Kisiel W, Connolly ES Jr, Pinsky DJ. Targeted inhibition of intrinsic coagulation limits cerebral injury in stroke without increasing intracerebral hemorrhage. J Exp Med 1999; 190: 91-9.
40. Choudhri TF, Hoh BL, Solomon RA, Connolly ES Jr, Pinsky DJ. Use of a spectrophotometric hemoglobin assay to objectively quantify intracerebral hemorrhage in mice. Stroke 1997; 28: 2296-302.
41. Koch R. Über bakteriologische Forschung. Verhandlungen des X International Medical Congress Berlin, 4-9 August 1890. 1891; 1 (Abstr.): 35-47.
42. Belayev L, Khoutorova L, Deisher TA, Belayev A, Busto R, Zhang Y, Zhao W, Ginsberg MD. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats. Stroke 2003; 34: 758-63.
43. Enjyoji K, Sévigny J, Lin Y, Frenette PS, Christie PD, Esch JS, Imai M, Edelberg JM, Rayburn H, Lech M, Beeler DL, Csizmadia E, Wagner DD, Robson SC, Rosenberg RD. Targeted disruption of CD39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nat Med 1999; 5: 1010-7.
44. Birk AV, Bubman D, Broekman MJ, Robertson HD, Drosopoulos JHF, Marcus AJ, Szeto HH. Role of a novel soluble nucleotide phosphohydrolase from sheep plasma in inhibition of platelet reactivity. J Lab Clin Med 2002; 139: 116-24.
45. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R, McKeown-Eyssen G, Summers RW, Rothstein R, Burke CA, Snover DC, Church TR, Allen JI, Beach M, Beck GJ, Bond JH, Byers T, Greenberg ER, Mandel JS, Marcon N, Mott LA, Pearson L, Saibil F, van Stolk RU. A randomized trial of aspirin to prevent colorectal adenomas. NEngl J Med 2003; 348: 891.
46. Al-Mondhiry H, Marcus AJ, Spaet TH. On the mechanism of platelet function inhibition by acetylsalicylic acid. Proc Soc Exp Biol Med 1970; 133: 632-6.
47. von Schacky C, Marcus AJ, Safier LB, Ullman HL, Islam N, Broekman MJ, Fischer S. Platelet-neutrophil interactions 12S,20and 5S,12Sdihydroxyeicosapentaenoic acids: two novel neutrophil metabolites from platelet-derived 12S-hydroxyeicosapentaenoic acid. J Lipid Res 1990; 31: 801-10.
48. Lorenzet R, Niemetz J, Marcus AJ, Broekman MJ. Enhancement of mononuclear procoagulant activity by platelet 12-hydroxyeicosatetraenoic acid. J Clin Invest 1986; 78: 418-23.
49. 4. J Pharmacol Exp Ther 2002; 300: 385-92.
50. Valles J, Santos MT, Aznar J, Osa A, Lago A, Cosin J, Sanchez E, Broekman MJ, Marcus AJ. Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity. Circulation 1998; 97: 350-5.
51. von Kugelgen I, Allgaier C, Schobert A, Starke K. Co-release of noradrenaline and ATP from cultured sympathetic neurons. Neuroscience 1994; 61: 199-202.
52. Sneddon P, Westfall TD, Todorov LD, Mihaylova-Todorova S, Westfall DP, Kennedy C. Modulation of purinergic neurotransmission. Prog Brain Res 1999; 120: 11-20.
53. Zimmermann H, Braun N. Ecto-nucleotidases-molecular structures, catalytic properties, and functional roles in the nervous system. Prog Brain Res 1999; 120: 371-85.
54. Burnstock G. Current status of purinergic signalling in the nervous system. Prog Brain Res 1999; 120: 3-10.
55. Boehm S. ATP stimulates sympathetic transmitter release via presynaptic P2X purinoceptors. J Neurosci 1999; 19: 737-46.
56. Benedict CR, Shelton B, Johnstone DE, Francis G, Greenberg B, Konstam M, Probstfield JL, Yusuf et S. Prognostic significance of plasma norepinephrine in patients with asymptomatic left ventricular dysfunction. SOLVD Investigators. Circulation 1996; 94: 690-7.
57. Braunwald E, Sobel BE. Coronary blood flow and myocardial ischemia. In: Braunwald, E, ed. Heart Disease, A Textbook of Cardiovascular Medicine. Philadelphia: W.B. Saunders, 1988: 1191-221.
58. Valles J, Santos MT, Marcus AJ, Safier LB, Broekman MJ, Islam N, Ullman HL, Aznar J. Down-regulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins. J Clin Invest 1993; 92: 1357-65.
59. Alexander JJ, Miguel R, Graham D. Low density lipoprotein uptake by an endothelial-smooth muscle cell bilayer. J Vasc Surg 1991; 13: 444-51.